TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms
Clinical trial NCT03503968 · TERMINATED
Trial details
- NCT number
- NCT03503968
- Sponsor
- Medigene AG
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-27
- Primary completion
- 2022-06-28
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.